Direct Rx recalls Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By A
Recalled March 9, 2022 · FDA recall D-0637-2022 · Direct Rx
Hazard
Failed impurities/degradation specifications · FDA Class II
Units
44 bottles
Sold at
Florida
Description
Failed impurities/degradation specifications
Product
Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By Aurobindo Pharma USA, Inc. East Windsor, NJ 08520, NDC 72189-076-05
Manufacturer(s)
Direct Rx
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →